What does CUSIP 15117F500 represent in this 13F holders report?

CUSIP 15117F500 is the security identifier for CLRB - Cellectar Biosciences, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held CLRB - Cellectar Biosciences, Inc. - Common Stock in Q3 2018?

9 institutional investors reported CLRB - Cellectar Biosciences, Inc. - Common Stock for Q3 2018. Use the holders table for investor-level position and value details.

Cellectar Biosciences, Inc. - Common Stock (CLRB)

CUSIP: 15117F500

Q3 2018 13F Holders as of 30 Sep 2018

Type / Class: Equity / Common Stock
Shares outstanding: 8,719,970
Total 13F shares: 203,047
Share change: +130,664
Total reported value: $611,000
Price per share: $3.01
Number of holders: 9
Value change: +$567,000
Number of buys: 9
Number of sells: 1

Quarterly Holders Quick Answers

What is CUSIP 15117F500?
CUSIP 15117F500 identifies CLRB - Cellectar Biosciences, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2018
Previous quarter: Q2 2018

Recent filing periods for CUSIP 15117F500:

Q2 2023 Q1 2023 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021

Top shareholders of CLRB - Cellectar Biosciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
VANGUARD GROUP INC	13F	Company	— class O/S missing	247,002	$153,000	—	30 Jun 2018	13F
Virtu Financial LLC	13F	Company	— class O/S missing	94,631	$59,000	—	30 Jun 2018	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.83%	72,383	$44,000	—	30 Jun 2018	13F
CITADEL ADVISORS LLC	13F	Company	— class O/S missing	56,299	$35,000	—	30 Jun 2018	13F
STATE STREET CORP	13F	Company	— class O/S missing	54,700	$34,000	—	30 Jun 2018	13F
TWO SIGMA SECURITIES, LLC	13F	Company	— class O/S missing	32,552	$20,000	—	30 Jun 2018	13F
AWM Investment Company, Inc.	13F	Company	— class O/S missing	106,600	$19,000	—	30 Jun 2018	13F
Iron Gate Global Advisors LLC	13F	Company	— class O/S missing	30,898	$19,000	—	30 Jun 2018	13F
NORTHERN TRUST CORP	13F	Company	— class O/S missing	28,648	$18,000	—	30 Jun 2018	13F
US BANCORP \DE\	13F	Company	— class O/S missing	28,570	$18,000	—	30 Jun 2018	13F
MORGAN STANLEY	13F	Company	— class O/S missing	5,215	$3,000	—	30 Jun 2018	13F
Sonora Investment Management, LLC	13F	Company	— class O/S missing	5,000	$3,000	—	30 Jun 2018	13F
Wealthspire Advisors, L.P.	13F	Company	— class O/S missing	994	$1,000	—	30 Jun 2018	13F
American Portfolios Advisors	13F	Company	— class O/S missing	1	$1	—	30 Jun 2018	13F

Institutional Holders of Cellectar Biosciences, Inc. - Common Stock (CLRB) as of Q3 2018

As of 30 Sep 2018, Cellectar Biosciences, Inc. - Common Stock (CLRB) was held by 9 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 203,047 shares. The largest 9 holders included SPHERA FUNDS MANAGEMENT LTD., RENAISSANCE TECHNOLOGIES LLC, MORGAN STANLEY, Vanguard Group Inc, DIMENSIONAL FUND ADVISORS LP, US BANCORP \DE\, UBS Group AG, Vigilant Capital Management, LLC, and BANK OF AMERICA CORP /DE/. This page lists 9 institutional shareholders reporting positions in this security for the Q3 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2018 vs Q2 2018 Across Filers

Q2 2018 holders

Q3 2018 holders

Holder diff

Investor	Q2 2018 Shares	Q3 2018 Shares	Share Diff	Share Chg %	Q2 2018 Value $	Q3 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.